Financial Ratios

ZORA PHARMA LTD.

NSE : NABSE : 524438ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsSep2005Sep2004Sep2003Sep2002Sep2001
Operational & Financial Ratios
   Earnings Per Share (Rs)-4.53-4.56-4.46-4.11-10.23
   CEPS(Rs)-3.30-3.22-2.97-2.47-8.35
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-29.56-25.03-20.51-16.18-12.22
   Tax Rate(%)-0.050.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)0.00-1228.50-152.70-173.91-166.10
   EBIT Margin(%)0.00-2957.69-268.22-111.99-215.55
   Pre Tax Margin(%)0.00-9468.94-957.06-520.88-336.64
   PAT Margin (%)0.00-9468.94-957.06-520.88-336.64
   Cash Profit Margin (%)0.00-6678.70-637.88-312.19-274.63
Performance Ratios
   ROA(%)-28.10-25.77-22.33-18.39-38.49
   ROE(%)0.000.000.000.000.00
   ROCE(%)-15.49-13.83-10.94-7.09-39.48
   Asset Turnover(x)0.000.020.040.11
   Sales/Fixed Asset(x)0.000.020.030.10
   Working Capital/Sales(x)0.00-0.01-0.13-0.18-0.66
Efficiency Ratios
   Fixed Capital/Sales(x)0.00591.5561.4236.229.70
   Receivable days0.008161.361164.19707.20160.54
   Inventory Days0.003866.18559.10567.01419.73
   Payable days0.000.006395.074047.57515.55
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.00914.9289.5749.3312.40
   EV/Core EBITDA(x)-280.27-546.38172.2848.86-7.41
   EV/EBIT(x)-33.98-30.93-32.73-42.19-5.28
   EV/CE(x)3.072.632.191.751.48
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-98.74-89.45-39.63-72.86-83.96
   Core EBITDA Growth(%)-109.94-133.98-68.91116.3632.34
   EBIT Growth(%)1.96-14.02-41.2986.5035.64
   PAT Growth(%)0.74-2.30-8.3959.8037.43
   EPS Growth(%)0.74-2.30-8.3959.8037.43
Financial Stability Ratios
   Total Debt/Equity(x)-1.29-1.38-1.54-1.73-2.07
   Current Ratio(x)0.450.460.500.520.52
   Quick Ratio(x)0.390.390.420.420.35
   Interest Cover(x)-0.45-0.45-0.39-0.27-1.78
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.